Our Publications

Click on a year to expand publications for that year.

Alternatively, click the search icon in the top right corner of this page to search for the publication.

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers.

Authors Zhang YD, Hurson AN, Zhang H, et al.
Citation Nat Commun. 2020 Jul 3;11(1):3353.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32620889/
PMCID PMC7335068
Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants.

Authors Campbell PT, Lin Y, Bien SA, Figueiredo JC, et al.
Citation JNCI. 2020 Apr 23.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32324875/
PMCID PMC7781451
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like GrowthFactor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and MendelianRandomization Analyses.

Authors Murphy N, Carreras-Torres R, Song M, et al.
Citation Gastoenterology. 2020 Apr;158(5).
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31884074/
PMCID PMC7152801
A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors.

Authors Zheng Y, Hua X, Win AK, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):549-557.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31932410/
PMCID PMC7060114
Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.

Authors Cornish AJ, Law PJ, Timofeeva M, et al.
Citation Lancet Gastroenterol Hepatol. 2020 Jan;5(1):55-62.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31668584/
PMCID PMC7026696
Genetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer.

Authors Neumeyer S, Butterbach K, Banbury BL, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2020Mar 18.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32188599/
PMCID PMC7269850
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.

Authors Dimou NL, Papadimitriou N, Mariosa D, et al.
Citation Int J Cancer. 2020 Oct 10.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33038280/
PMCID PMC7894468
Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.

Authors Neumeyer S, Hua X, Seibold P, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2719-2728.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33008876/
PMCID PMC7976673
A general framework for functionally informed set-based analysis: Application to a large-scale colorectal cancer study.

Authors Dong X, Su YR, Barfield R, et al.
Citation Plos Genetics. 2020 Aug 24;16(8):e1008947.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32833970/
PMCID PMC7470748
A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer.

Authors Nounu A, Greenhough A, Heesom KJ, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2020 Dec 14;cebp.1176.2020.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33318029/
PMCID PMC8086774
Monoallelic NTHL1 Loss of Function Variants and Risk of Polyposis and Colorectal Cancer.

Authors Elsayed FA, Grolleman JE, Ragunathan A, et al.
Citation Gastroenterology. 2020 Aug 26;S0016-5085(20)35113-1.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32860789/
PMCID PMC7899696
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis.

Authors Papadimitriou N, Dimou N, Tsilidis KK, et al.
Citation Nat Commun. 2020 Jan 30;11(1):597.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32001714/
PMCID PMC6992637
Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation?

Authors Gemechu SD, van Vliet CM, Win AK, et al.
Citation Fam Cancer. 2020 Feb 27.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32107660/
PMCID PMC7410789
A Latent Unknown Clustering Integrating Multi-Omics Data (LUCID) With Phenotypic Traits.

Authors Peng C, Wang J, Asante I, et al.
Citation Bioinformatics. 2020 Feb 1;36(3):842-850.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31504184/
PMCID PMC7986585
Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.

Authors Guo X, Lin W, Wen W, Huyghe J, et al.
Citation Gastroenterology. 2020 Oct 12; S0016-5085(20)35243-4.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33058866/
PMCID PMC7956223
Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.

Authors Phipps AI, Alwers E, Harrison T, et al.
Citation Gastroenterology. 2020 Jun;158(8):2158-2168.e4.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32088204/
PMCID PMC7282955
Height and Colorectal and Endometrial Cancer Risk for Persons with Lynch Syndrome.

Authors Brouwer JGM, Newcomb PA, Bisseling TM, et al.
Citation Am J Epidemiol. 2020 Aug 17:kwwaa175.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33524116/
PMCID PMC8210745
Potential impact of family history-based screening guildelines on the detection of early-onset colorectal cancer.

Authors Gupta S, Bharti B, Ahnen DJ, et al
Citation Cancer. 2020 Apr 20.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/32307706/
PMCID PMC7702222
The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.

Authors Saya S, Emery JD, Dowty JG, et al.
Citation JNCI Cancer Spectrum. 2020 Oct; 4(5):
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33134836/
PMCID PMC7583148
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Authors Jenkins MA, Win AK, Dowty JG, et al.
Citation Fam Cancer. 2019 Jun 17.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31209717/
PMCID PMC6785388
Shared heritability and functional enrichment across six solid cancers.

Authors Jiang X, Finucane HK, Schumacher FR, et al.
Citation Nat Commun. 2019 Jan 25;10(1):431.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30683880/
PMCID PMC6347624
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.

Authors Law PJ, Timofeeva M, Fernandez-Rozadilla C, et al.
Citation Nat Commun. 2019 May 14;10(1):2154.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31089142/
PMCID PMC6517433
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.

Authors Lu Y, Kweon SS, Tanikawa C, et al.
Citation Gastroenterology. 2019 Apr;156(5):1455-1466.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30529582/
PMCID PMC6441622
DNA repair and cancer in colon and rectum: novel players in genetic susceptibility.

Authors Pardini B, Corrado A, Paolicchi E, et al.
Citation Int J Cancer. 2019 Jun 17.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31209889/
PMCID PMC7301215
Genome-wide association study of circulating folate one-carbon metabolites.

Authors Wang J, Asante I, Baron JA, et al.
Citation Genet Epidemiol. 2019 Sep 10.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31502714/
PMCID PMC6829035
Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.

Authors Wang X, Dai JY, Albanes D, et al.
Citation Int J Epidemiol. 2018 Nov 21.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30476131/
PMCID PMC6659358
Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies.

Authors Wang X, O’Connell K, Jeon J, et al.
Citation BMJ Open Gastroenterol. 2019 Dec 2;6(1):e000339.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31875139/
PMCID PMC6904202
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-onset vs Late-onset Cancer.

Authors Archambault AN, Su YR, Jeon J, et al.
Citation Gastroenterology. 2019 Dec 19.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31866242/
PMCID PMC7103489
Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer.

Authors Bien SA, Su YR, Conti DV, et al.
Citation Hum Genet. 2019 Feb 28.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30820706/
PMCID PMC6483948
Type 2 diabetes mellitus, blood cholesterol, triglycerideand colorectal cancer risk in Lynch syndrome.

Authors Dashti SG, Li WY, Buchanan DD, et al.
Citation Br J Cancer. 2019 Sep 25.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31551580/
PMCID PMC6888855
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Authors Dominguez-Valentin M, Sampson JR, Seppälä TT, et al.
Citation Genet Med. 2019 Jul 24.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31337882/
PMCID PMC7371626
Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial.

Authors Esplen MJ, Harrington S, Leung YW, et al.
Citation Cancer. 2019 Mar 12.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30861097/
PMCID PMC6742581
Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.

Authors Georgeson P, Walsh MD, Clendenning M, et al.
Citation Mol Genet Genomic Med. 2019 Jun 4;e781.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/31162827/
PMCID PMC6625139
Discovery of common and rare genetic risk variants for colorectal cancer.

Authors Huyghe JR, Bien SA, Harrison TA, et al.
Citation Nat Genet. 2019 Jan;51(1):76-87.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30510241/
PMCID PMC6358437
Physical activity and the risk of colorectal cancer in Lynch syndrome.

Authors Dashti SG, Win AK, Hardikar SS, et al.
Citation Int J Cancer. 2018 Jun 14.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29904935/
PMCID PMC6195467
Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.

Authors Wang X, Chan AT, Slattery ML, et al.
Citation Cancer Res. 2018 Aug 15;78(16):4790-4799.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29921691/
PMCID PMC6095723
Family history-based colorectal cancer screening in Australia: a modelling study of the costs, benefits and harms of different participation scenarios.

Authors Dillon M, Flander L, Buchanan DD, et al.
Citation Plos Medicine. 2018 Aug 16;15(8):e1002630.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30114221/
PMCID PMC6095490
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients with Lynch Syndrome.

Authors Donahue TF, Bagrodia A, Audenet F, et al.
Citation JCO Precision Oncology. 2018 Jan 23.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30854504/
PMCID PMC6404976
RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Authors Fennell LJ, Clendenning M, McKeone DM, et al.
Citation Fam Cancer. 2018 Jan;17(1):63-69.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28573495/
PMCID PMC6086823
Symptom Severity and Quality of Life Among Long-Term Colorectal Cancer Survivors Compared with Matched Control Subjects: A Population-Based Study.

Authors Hart TL, Charles ST, Gunaratne M, et al.
Citation Dis Colon Rectum. 2018 Jan 24.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29377871/
PMCID PMC5805591
Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study.

Authors He Y, Timofeeva M, Farrington SM, et al.
Citation BMC Med. 2018 Aug 14;16(1):142.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30103784/
PMCID PMC6090711
Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors Jenkins MA, Win AK, Templeton AS, et al.
Citation Int J Epidemiol. 2018 Feb 27.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29490034/
PMCID PMC5913593
Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline.

Authors Kanga-Parabia A, Gaff C, Flander L, et al.
Citation Fam Cancer. 2018 Feb 20.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29464398/
PMCID PMC6102092
Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis.

Authors Carr PR, Banbury B, Berndt SI, et al.
Citation Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31279-5.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30476588/
PMCID PMC6533164
Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer.

Authors Neumeyer S, Banbury BL, Arndt V, et al.
Citation Br J Cancer. 2018 Jun;118(12):1639-1647.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29795306/
PMCID PMC6008474
Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.

Authors Cenin DR, Naber SK, Lansdorp-Vogelaar I, et al.
Citation J Gastroenterol Hepatol. 2018 Oct;33(10):1737-1744.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29645364/
PMCID PMC6403824
DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Authors Pai RK, Dudley B, Karloski E, et al.
Citation Mod Pathol. 2018 Jun 8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29884888/
PMCID PMC6396289
Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.

Authors Choi YH, Lakhal-Chaieb L, Kröl A, et al.
Citation J Natl Cancer Inst. 2018 Oct 30.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30380125/
PMCID PMC7514801
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.

Authors Pande M, Joon A, Brewster AM, et al.
Citation PLoS One. 2018 Apr 26;13 (4): e0196245.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29698419/
PMCID PMC5919670
Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies.

Authors Chong DQ, Banbury BL, Phipps AI, et al.
Citation Cancer Med. 2018 May;7(5):2192-2199.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29582567/
PMCID PMC5943468
Novel common genetic susceptibility loci for colorectal cancer.

Authors Schmit SL, Edlund CK, Schumacher FR, et al.
Citation J Natl Cancer Inst. 2019 Feb 1;111(2):146-157.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29917119/
PMCID PMC6555904
Leptin gene variants and colorectal cancer risk: Sex-specific associations.

Authors Chun KA, Kocarnik JM, Hardikar SS, et al.
Citation PLoS One. 2018 Oct 31;13(10):e0206519.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30379922/
PMCID PMC6209341
Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.

Authors Sheth H, Northwood E, Ulrich CM, et al.
Citation PloS One. 2018 Feb 9;13(2):e0192223.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29425227/
PMCID PMC5806861
Laxative type in relation to colorectal cancer risk.

Authors Citronberg JS, Hardikar S, Phipps A, et al.
Citation Ann Epidemiol. 2018 Jul 9. pii: S1047-2797(18)30109-1.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30150160/
PMCID PMC6415945
A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics.

Authors Su YR, Di C, Bien S, et al.
Citation Am J Hum Genet. 2018 May 3;102(5):904-919.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29727690/
PMCID PMC5986723
Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.

Authors Clendenning M, Huang A, Jayasekara H, et al.
Citation Fam Cancer. 2018 Jan;17(1):91-100.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28616688/
PMCID PMC6129400
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.

Authors Tanskanen T, van den Berg L, Välimäki N, et al.
Citation Int J Cancer. 2018 Feb 1;142(3):540-546.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28960316/
PMCID PMC6383773
Diagnostics of Pleiotropy in Mendelian randomization Studies: Global and Individual Tests for Direct Effects.

Authors Dai JY, Peters U, Wang X, et al.
Citation Am J Epidemiol. 2018 Sep 5.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30188971/
PMCID PMC6269243
Cancer risks for PMS2-associated Lynch syndrome.

Authors ten Broeke SW, van der Klift H, Tops C, et al.
Citation J Clin Oncol. 2018 Oct 10;36(29):2961-2968.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/30161022/
PMCID PMC6349460
Germline miRNA DNA variants and the risk of colorectal cancer by subtype.

Authors Lindor NM, Larson MC, DeRycke MS, et al.
Citation Genes Chromosomes Cancer. 2017 Mar;56(3):177-184.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27636879/
PMCID PMC5245119
Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.

Authors Bien SA, Auer PL, Harrison TA, et al.
Citation PLoS One. 2017 Nov 21;12(11):e0186518.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29161273/
PMCID PMC5697874
Quantifying the Genetic Correlation between Multiple Cancer Types.

Authors Lindström S, Finucane H, Bulik-Sullivan B, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1427-1435.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28637796/
PMCID PMC5582139
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.

Authors Buchanan DD, Clendenning M, Rosty C, et al.
Citation J Gastroenterol Hepatol. 2017 Feb;32(2):427-438.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27273229/
PMCID PMC5140773
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.

Authors May-Wilson S, Sud A, Law PJ, et al.
Citation Eur J Cancer. 2017 Aug 19;84:228-238.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28829991/
PMCID PMC5630201
Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.

Authors Buchanan DD, Clendenning M, Zhuoer L, et al.
Citation Gut. 2017 Jun;66(6):1170-1172.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27582512/
PMCID NA
Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.

Authors Phipps AI, Robinson JR, Campbell PT, et al.
Citation Cancer. 2017 May 15;123(6):1035-1043.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27861761/
PMCID PMC5339045
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Authors Buchanan DD, Stewart JR, Clendenning M, et al.
Citation Genet Med. 2017 Nov 9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29120461/
PMCID PMC5943186
Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.

Authors Raskin L, Guo Y, Du L, et al.
Citation Oncotarget. 2017 Jun 21;8(55):93450-93463.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29212164/
PMCID PMC5706810
Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas.

Authors Choi YH, Briollais L, Win AK, et al.
Citation Biometrics. 2017 Mar;73(1):271-282.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27378229/
PMCID PMC5319907
Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.

Authors Rodriguez-Broadbent H, Law PJ, Sud A, et al.
Citation Int J Cancer. 2017 Jun 15;140(12):2701-2708.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28340513/
PMCID PMC6135234
Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.

Authors Dashti SG, Buchanan DD, Jayasekara H, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27811119/
PMCID PMC5336397
The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.

Authors Savio AJ, Mrkonjic, Lemire M, et al.
Citation Clin. Epigenetics. 2017 Mar 9;9:26.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28293327/
PMCID PMC5345264
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.

Authors DeRycke MS, Gunawardena S, Balcom JR, et al.
Citation Mol Genet Genomic Med. 2017 Jul 23;5(5):553-569.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28944238/
PMCID PMC5606870
How does genetic risk information for Lynch syndrome translate to risk management behaviours?

Authors Steel E, Robbins A, Jenkins M, et al.
Citation Hered Cancer Clin Pract. 2017 Jan 5;15:1.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28070225/
PMCID PMC5217251
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.

Authors Dienstmann R, Mason MJ, Sinicrope FA, et al.
Citation Ann Oncol. 2017 May 1;28(5):1023-1031.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28453697/
PMCID PMC5406760
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.

Authors Toth R, Scherer D, Kelemen LE, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2017 Jan 23.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28115406/
PMCID PMC6054308
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.

Authors Dimitrakopoulou VI, Tsilidis KK, Haycock PC, et al.
Citation BMJ. 2017 Oct 31;359.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29089348/
PMCID PMC5666592
Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.

Authors Wang H, Schmit SL, Haiman CA, et al.
Citation Int J Cancer. 2017 Jun 15;140(12):2728-2733.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28295283/
PMCID PMC5505639
Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.

Authors Dite GS, MacInnis RJ, Bickerstaffe A, et al.
Citation Am J Epidemiol. 2017 Mar 15;185(6):487-500.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28399571/
PMCID PMC6158796
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.

Authors Gu F, Zhang H, Hyland PL, et al.
Citation Int J Cancer. 2017 Nov 1;141(9):1794-1802.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28699174/
PMCID PMC5907928
Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients with Colorectal Cancer in Relation to Tumor Markers and Survival.

Authors Hua X, Phipps AI, Burnett-Hartman AN, et al.
Citation J Clin Oncol. 2017 Aug 20;35(24):2806-2813.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28617623/
PMCID PMC5562174
Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.

Authors Keogh LA, Niven H, Rutstein A, et al.
Citation J Behav Med. 2017 Aug;40(4):583-594.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28197815/
PMCID PMC6057776
Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry.

Authors Kocarnik JM, Hua X, Hardikar S, et al.
Citation Cancer. 2017 Aug 25.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28841225/
PMCID PMC5693760
Clinical verification of genetic results returned to research participants: findings from a Colon Cancer Family Registry.

Authors Laurino MY, Truitt AR, Tenney L, et al.
Citation Mol Genet Genomic Med. 2017 Nov;5(6):700-708.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/29178651/
PMCID PMC5702564
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.

Authors Garcia-Albeniz X, Rudolph A, Hutter C, et al.
Citation Br J Cancer. 2016 Jan 19;114(2):221-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/26766742/
PMCID PMC4815813
Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.

Authors Shang J, Reece JC, Buchanan DD, et al.
Citation Int J Colorectal Dis. 2016 Aug;31(8):1451-7.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27286977/
PMCID PMC4949040
Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer.

Authors Gong J, Hutter CM, Newcomb PA, et al.
Citation PLoS Genet. 2016 Oct 10;12(10):e1006296.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27723779/
PMCID PMC5065124
Winner’s Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data.

Authors Shi J, Park JH, Duan J, et al.
Citation PLoS Genet. 2016 Dec 30;12(12):e1006493.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/28036406/
PMCID PMC5201242
PMS2 monoallelic mutation carriers: the known unknown.

Authors Goodenberger ML, Thomas BC, Riegert-Johnson D, et al.
Citation Genet Med. 2016 Jan;18(1):13-9.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/25856668/
PMCID PMC4834863
The Experience of Extended Bowel Resection in Individuals With a High Metachronous Colorectal Cancer Risk: A Qualitative Study.

Authors Steel EJ, Trainer AH, Heriott AG, et al.
Citation Oncol Nurs Forum. 2016 Jul 1;43(4):444-52.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27314187/
PMCID PMC5114664
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.

Authors Jarvis D, Mitchell JS, Law PJ, et al.
Citation Br J Cancer. 2016 Jul 12;115(2):266-72.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27336604/
PMCID PMC4947703
Prevalence and penetrance of major genes and polygenes for colorectal cancer.

Authors Win AK, Jenkins MA, Dowty JG, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2016 Oct 31.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27799157/
PMCID PMC5336409
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Authors Jayasekara H, Reece JC, Buchanan DD, et al.
Citation Int J Cancer. 2016. 139, 1081-1090.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27098183/
PMCID PMC4911232
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Authors Win AK, Reece JC, Dowty JG, et al.
Citation Int J Cancer. 2016 Oct 1;139(7):1557-63.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27194394/
PMCID PMC5094810
Telomere structure and maintenance gene variants and risk of five cancer types.

Authors Karami S, Han Y, Pande M, et al.
Citation Int J Cancer. 2016 Dec 15;139(12):2655-2670.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27459707/
PMCID PMC5198774
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Authors Xicola RM, Bontu S, Doyle BJ, et al.
Citation Carcinogenesis. 2016 Aug;37(8):751-8.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27234654/
PMCID PMC4967215
The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Authors Kim JS, Coyte PC, Cotterchio M, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1524-1533.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27528600/
PMCID PMC5274544
Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer.

Authors Yang B, Thrift AP, Figueiredo JC, et al.
Citation Cancer Epidemiol. 2016 Oct;44:1-4.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27449576/
PMCID PMC5125024
SNP rs16906252C>T is an expression and methylation quantitative trait locus associated with an increased risk of developing MGMT-methylated colorectal cancer.

Authors Kuroiwa-Trzmielina J, Wang F, Rapkins RW, et al.
Citation Clin Cancer Res. 2016 Dec 15;22(24):6266-6277.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/27267851/
PMCID PMC5143212
Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.

Authors Zeng C, Matsuda K, Jia WG, et al.
Citation Gastroenterology. 2016 Jun;150(7):1633-45.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/26965516/
PMCID PMC4909543

2007

2006

2005

2004

2003

2002

2001

2000

1999

Click on a year to expand publications for that year.

Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers.

Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants.

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like GrowthFactor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and MendelianRandomization Analyses.

A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors.

Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.

Genetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer.

Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.

Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.

A general framework for functionally informed set-based analysis: Application to a large-scale colorectal cancer study.

A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer.

Monoallelic NTHL1 Loss of Function Variants and Risk of Polyposis and Colorectal Cancer.

Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis.

Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation?

A Latent Unknown Clustering Integrating Multi-Omics Data (LUCID) With Phenotypic Traits.

Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.

Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.

Height and Colorectal and Endometrial Cancer Risk for Persons with Lynch Syndrome.

Potential impact of family history-based screening guildelines on the detection of early-onset colorectal cancer.

The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Shared heritability and functional enrichment across six solid cancers.

Association analyses identify 31 new risk loci for colorectal cancer susceptibility.

Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.

DNA repair and cancer in colon and rectum: novel players in genetic susceptibility.

Genome-wide association study of circulating folate one-carbon metabolites.

Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.

Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies.

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-onset vs Late-onset Cancer.

Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer.

Type 2 diabetes mellitus, blood cholesterol, triglycerideand colorectal cancer risk in Lynch syndrome.

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial.

Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.

Discovery of common and rare genetic risk variants for colorectal cancer.

Physical activity and the risk of colorectal cancer in Lynch syndrome.

Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.

Family history-based colorectal cancer screening in Australia: a modelling study of the costs, benefits and harms of different participation scenarios.

Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients with Lynch Syndrome.

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Symptom Severity and Quality of Life Among Long-Term Colorectal Cancer Survivors Compared with Matched Control Subjects: A Population-Based Study.

Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study.

Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline.

Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis.

Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer.

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.

DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.

Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.

Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies.

Novel common genetic susceptibility loci for colorectal cancer.

Leptin gene variants and colorectal cancer risk: Sex-specific associations.

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.

Laxative type in relation to colorectal cancer risk.

A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics.

Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.

Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.

Diagnostics of Pleiotropy in Mendelian randomization Studies: Global and Individual Tests for Direct Effects.

Cancer risks for PMS2-associated Lynch syndrome.

Germline miRNA DNA variants and the risk of colorectal cancer by subtype.

Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.

Quantifying the Genetic Correlation between Multiple Cancer Types.

Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.

Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.

Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.

Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.

Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.

Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas.

Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.

Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.

The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.

Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.

How does genetic risk information for Lynch syndrome translate to risk management behaviours?

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.

Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.

Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.

Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.